|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-8-2
|
|
pubmed:abstractText |
Antiarrhythmic potential of mexiletine in patients with congenital and acquired long-QT syndrome (LQTS) has been attributed to a reduction of transmural dispersion of repolarization (TDR). A similar mechanism could be involved in the antiarrhythmic activity of the drug in patients with normal QT intervals, but the issue remains to be investigated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0167-5273
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
3
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
92-7
|
|
pubmed:dateRevised |
2010-3-29
|
|
pubmed:meshHeading |
pubmed-meshheading:16061129-Action Potentials,
pubmed-meshheading:16061129-Administration, Oral,
pubmed-meshheading:16061129-Aged,
pubmed-meshheading:16061129-Anti-Arrhythmia Agents,
pubmed-meshheading:16061129-Electrocardiography, Ambulatory,
pubmed-meshheading:16061129-Female,
pubmed-meshheading:16061129-Follow-Up Studies,
pubmed-meshheading:16061129-Heart Conduction System,
pubmed-meshheading:16061129-Heart Rate,
pubmed-meshheading:16061129-Humans,
pubmed-meshheading:16061129-Male,
pubmed-meshheading:16061129-Mexiletine,
pubmed-meshheading:16061129-Middle Aged,
pubmed-meshheading:16061129-Treatment Outcome,
pubmed-meshheading:16061129-Ventricular Premature Complexes
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization.
|
|
pubmed:affiliation |
Department of Cardiology, Gifu Shakai Hoken Hospital, Kani, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
